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Abstract
Aim: Suicidal thoughts and behaviours are prevalent in individuals with schizophre-
nia. However, research examining the prevalence and predictors of suicidality and
self-harm in participants at clinical high-risk for psychosis (CHR-P) is limited and
mostly focuses on help-seeking participants recruited through clinical pathways. The
current study sought to assess the prevalence of suicidality and self-harm and iden-
tify predictors of current suicidal ideation in community-recruited CHR-P
participants.
Methods: Data were available for 130 CHR-P participants, 15 participants with first-
episode psychosis (FEP), 47 participants not fulfilling CHR-P criteria (CHR-Ns) and
53 healthy controls. Current and lifetime suicidality and self-harm were assessed
using the Mini-International Neuropsychiatric Interview and the Comprehensive
Assessment of At-Risk Mental States (CAARMS). Multivariable logistic regression
analysis was used to determine predictors of current suicidal ideation in the CHR-P
group.
Results: A considerable proportion of CHR-P participants disclosed current suicidal
ideation (34.6%). Overall, FEP individuals were at greatest risk, with considerably high
prevalence rates for current suicidal ideation (73.3%), lifetime self-harm behaviour
(60.0%) and lifetime suicide attempt (60.0%). In the CHR-P sample, current suicidal
ideation was predicted by lifetime suicide attempts, lower CAARMS severity,
impaired social functioning and greater comorbidity.
Conclusions: Our findings suggest that suicidality and self-harm are highly prevalent
in community-recruited CHR-P and FEP individuals. Accordingly, these results high-
light the importance of further research into the determinants of suicidality and self-
harm during at-risk and early stages of psychosis, and the implementation of inter-
vention strategies to reduce adverse outcomes in these populations.
[Correction added on 13 January 2020, after first online publication: The data for FEP (2) in Table 1 were incorrect and have been amended. References to these data in the text have additionally
been amended throughout.]
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1 | INTRODUCTION
Psychotic disorders, such as schizophrenia, are strongly linked to high
levels of suicidality. Compared to the general population, individuals with
schizophrenia have a 13-fold greater risk of suicide (Too et al., 2019) and
approximately 4.9% die by suicide (Palmer et al., 2005). Individuals with
first-episode psychosis (FEP) comprise a particularly vulnerable group.
Indeed, suicide risk is elevated by 60% within the first year of treatment
relative to later stages (Nordentoft et al., 2004).
Research examining the prevalence of suicidality and self-harm in
individuals at clinical high-risk for psychosis (CHR-P) is more limited
albeit emerging (L. Pelizza et al., 2020; Taylor et al., 2015). CHR-P par-
ticipants are characterised using ultra-high risk (UHR) criteria, which
include attenuated psychotic symptoms, brief frank psychosis and
functional decline with genetic risk (Yung et al., 2005), as well as basic
symptom criteria relying on perceptual and cognitive disturbances
self-experienced with full and immediate insight (F. Schultze-
Lutter, 2009; F. Schultze-Lutter et al., 2012). Over a 2-year period,
around 20% of individuals meeting UHR criteria transition to psycho-
sis (P. Fusar-Poli, Cappucciati, et al., 2016). Moreover, in a UHR sam-
ple, approximately 45% of nonconverters experienced either poor
social or role outcome (Carrión et al., 2013); impairments previously
related to persistence of CHR-P symptoms (Michel et al., 2018).
A recent meta-analysis reported prevalence rates of 66% for cur-
rent suicidal ideation, 18% for lifetime suicide attempts and 49% for
lifetime self-harm behaviour in UHR samples, comparable to those
observed in FEP cohorts (Taylor et al., 2015).Furthermore, in a retro-
spective study of prodromal suicide risk among individuals with
schizophrenia, 25.5% had experienced suicidal ideation and 7.5% had
attempted suicide (Andriopoulos et al., 2011). More recently,
L. Pelizza et al. (2020) found that UHR individuals disclosed more
severe suicidal ideation and were more likely to report previous sui-
cide attempts than FEP and non-UHR/FEP samples. Therefore, there
is a need to further identify the factors underlying the emergence of
suicidality and self-harm in CHR-P populations.
However, relatively little is known about the predictors of
suicidality and self-harm in CHP-P individuals. Paranoid thinking,
depressive symptoms and impaired role functioning have been found
to predict current suicidal ideation (Andriopoulos et al., 2011; Bang
et al., 2017; L. Pelizza et al., 2019), while the presence of personality
disorders and history of trauma strongly predict suicide attempts
(Zuschlag et al., 2018), consistent with findings in established schizo-
phrenia and other psychiatric populations (Aaltonen et al., 2016;
Bornheimer, 2016; Fuller-Thomson & Hollister, 2016).Within these
latter cohorts, suicidal ideation and previous suicide attempts have
been identified as two of the strongest predictors of completed sui-
cide (Fosse et al., 2017; Lopez-Morinigo et al., 2016) and future sui-
cide attempts (Bertelsen et al., 2007; Horwitz et al., 2015).
To date, the majority of studies investigating suicidality and self-
harm in CHR-P populations involve help-seeking participants recruited
through clinical pathways by UHR criteria. Accordingly, it is unclear
whether the prevalence rates and predictors of suicidality and self-
harm identified in these studies generalise to more representative
community samples as well as CHR-P individuals recruited using UHR
and/or basic symptom criteria. This is an important question given
that recruitment pathways have been shown to impact on transition
rates in CHR-P samples. Indeed, pretest risk for psychosis, although
enriched in help-seeking samples, appears to be lower in community-
recruited samples, reducing the likelihood of subsequent transitions
(P. Fusar-Poli, Schultze-Lutter, et al., 2016).
In the current study, we sought to assess the prevalence of
suidicality and self-harm in community-recruited CHR-P and FEP par-
ticipants. We also included participants who did not fulfil CHR-P
criteria but were characterised by psychiatric comorbidities (CHR-Ns)
as well as a group of healthy controls (HCs). In addition, we aimed to
identify predictors of current suicidal ideation in the CHR-P group.
Social support, insecure attachment orientations and cognitive ability
were also investigated given their relation with suicidality in the gen-
eral population (E.M. Kleiman & Liu, 2013; Kosidou et al., 2014;
Sörberg et al., 2013; Zortea et al., 2019).
Given these findings, we hypothesised that (1) CHR-P and FEP
participants would show comparably higher levels of suicidality and
self-harm than CHR-N and HC participants and (2) a range of clinical,
functional and cognitive variables would emerge as significant predic-
tors of current suicidal ideation in CHR-P participants.
2 | METHODS
2.1 | Participants
Participants were recruited as part of the Youth Mental Health Risk
and Resilience (YouR) study(Uhlhaas et al., 2017), an ongoing longitu-
dinal study funded by the Medical Research Council which aims to
identify neurobiological and psychological mechanisms and predictors
of psychosis risk. Utilising an online-screening approach (McDonald
et al., 2019), potential CHR-P participants from the general population
were directed to our website (www.yourstudy.org.uk) via email invita-
tions, posters and flyers over a 4-year period. FEP and CHR-N partici-
pants were also recruited using this approach while HCs were
obtained from an existing volunteer database. Screening question-
naires comprised (a) the 16-item Prodromal Questionnaire (PQ-16;
Ising et al., 2012) and (b) a nine-item scale of Perceptual and Cognitive
Anomalies (PCA) for assessing basic symptoms. Participants were
invited for clinical interviews if they positively endorsed six or more
items on the PQ-16 and/or three or more items on the PCA.
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Data were available for 130 CHR-P individuals that were rec-
ruited across two sites: Glasgow (n = 94; 72.3%) and Edinburgh
(n = 36; 27.7%).We also obtained a community-recruited sample of
15 FEP participants, 47 CHR-N participants and 53 HCs.
2.2 | Instruments and measures
In order to establish CHR-P criteria, the positive scale of the Compre-
hensive Assessment of At-Risk Mental States (CAARMS; Yung
et al., 2005) and the Cognitive Disturbances (COGDIS) and Cognitive-
Perceptive Basic Symptoms (COPER) items of the Schizophrenia
Proneness Instrument, Adult version (SPI-A; F. Schultze-Lutter
et al., 2007) were administered by trained research assistants and
MSc/PhD level researchers. Participants were recruited into the
CHR-P group if they met SPI-A COGDIS/COPERcriteria and/or one
of the following CAARMS criteria: attenuated psychotic symptoms
(APS), genetic risk and functional deterioration (GRFD) or brief limited
intermittent psychotic symptoms. FEP criteria were established using
the Positive and Negative Syndrome Scale (Kay et al., 1987) as well as
the Structured Clinical Interview for DSM-IV (SCID; First et al., 2002).
Current (past month) and lifetime suicidality and self-harm were
assessed using the six-item suicidality module of the Mini-
International Neuropsychiatric Interview (MINI; Sheehan et al., 1998)
as well as questions contained in the CAARMS suicidality and self-
harm subscale. For FEP participants, only the latter assessment of
suicidality and self-harm was available.
In addition, with the exception of the FEP group, all participants
were assessed with the Global Functioning: Social (GF: Social) and
Role (GF: Role) scales (Cornblatt et al., 2007), Premorbid Adjustment
Scale (Cannon-Spoor et al., 1982), Adverse Childhood Experiences
Scale (Felitti et al., 1998), Psychosis Attachment Measure (Berry
et al., 2006), Significant Others Scale (Power et al., 1988)and Brief
Assessment of Cognition in Schizophrenia (BACS; Keefe
et al., 2004). Psychiatric comorbidity was calculated from the MINI
by summing the number of current comorbid Axis I disorders dis-
closed by participants from a possible total of five (mood disorder,
anxiety disorder, drug abuse/dependence, alcohol abuse/depen-
dence, eating disorder).
2.3 | Statistical methods
Data were analysed using SPSS version 26 with statistical significance
set at p < .05 (two-tailed). The BACS composite score was calculated
by averaging the z-scores obtained from the six primary measures and
re-standardizing this value using the means and standard deviations
of sex-specific HCs (Keefe et al., 2004). Overall, 1.2% of the data
(48 of 4,030 values) were missing and imputed by Bayesian
imputation.
Group differences were analysed using non-parametric Kruskal–
Wallis H tests and chi-square tests followed by appropriate
Bonferroni-corrected post hoc tests if required. Collinearity of
predictors was defined as any variance inflation factor (VIF) > 2 and
tolerance <0.40. Multivariable logistic regression analysis, using step-
wise backward selection (likelihood ratio), was employed to determine
predictors of current suicidal ideation in the CHR-P group. This out-
come variable was prioritised as it did not violate the events per vari-
able rule of 5:1 suggested by Vittinghoff and McCulloch (2007). The
overall variance explained by the model was measured by the
Nagelkerke pseudo R2 statistic (R2N). Diagnostic accuracy of the
model was determined using the area under the receiver-operating
characteristic curve (AUC).
3 | RESULTS
3.1 | Demographic data
CHR-P individuals were significantly impaired relative to CHR-N
and HC participants, displaying greater CAARMS and SPI-A sever-
ity, higher comorbidity, lower social and role functioning and
greater levels of insecure attachment (Table 1). As expected, FEP
participants had significantly higher CAARMS severity compared to
all other groups and greater antipsychotic use compared to CHR-P
participants. Although significant group differences emerged for
age, these effects did not survive Bonferroni-corrected post hoc
tests.
A significantly larger proportion of FEP and CHR-P participants
received current or past treatment compared to HCs (Table 1).
Twenty percent of FEP participants and 16.2% of CHR-P participants
were in current treatment while 60.0% of FEP participants and 45.4%
of CHR-P participants received past treatment. CHR-N participants
(31.9%) were also significantly more likely than HCs (5.7%) to have
engaged in past treatment.
In addition, among the CHR-P group, 39 (30.0%) met CAARMS
criteria, 32 (24.6%) met SPI-A criteria and 59 (45.4%) met both. Of
those meeting CAARMS, 95.9% met APS criteria, 2.0% met GRFD
criteria and 2.0% met both APS and GRFD criteria; while, of those
meeting SPI-A criteria, 46.2% met COPER criteria, 14.3% met COG-
DIS criteria and 39.6% met both. Furthermore, the FEP group con-
sisted of participants with SCID DSM-IV psychotic disorder not
otherwise specified (n = 7; 46.7%), schizophrenia (n = 6; 40.0%) and
schizoaffective disorder (n = 2; 13.3%).
3.2 | Suicidality and self-harm prevalence
Lifetime suicide attempts were significantly more prominent in indi-
viduals meeting CHR-P (29.2%) and FEP (60.0%) criteria compared to
CHR-N (8.5%) and HC (0%) participants (Table 1; Figure 1). In addi-
tion, relative to HCs, CHR-P participants more commonly disclosed
current suicidal ideation (34.6%), current self-harm intention (28.5%)
and lifetime self-harm behaviour (28.5%) whilst CHR-N participants
were more likely to report current suicidal ideation (19.1%). Current
self-harm intention was also reported significantly more in CHR-P
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than in CHR-N individuals (28.5 vs. 8.5%). Overall, 32.4% of CHR-P
and 17.0% of CHR-N participants were categorised as currently at
moderate- to high-risk of suicide. The FEP group was at greatest risk,
with considerably high prevalence rates for current suicidal ideation
(73.3%), lifetime self-harm behaviour (60.0%) and lifetime suicide
attempt (60.0%).
3.3 | Impact of recruitment pathway
We further compared our community-recruited CHR-P sample to a
smaller group of CHR-P individuals (n = 16) recruited via referrals from
clinical services in NHS Greater Glasgow and Clyde and NHS Lothian
as well as student counselling services (Table S1). Referred








(N = 53) P Effect sizea Post hoc testb
Age (years), mean (SD) 21.64 (4.27) 23.73 (4.79) 22.94 (4.80) 22.42 (3.36) .044 η2p = 0.033 
Gender, female n (%) 94 (72.3) 10 (66.7) 30 (63.8) 36 (67.9) .727 V = 0.073 
Education (years), mean (SD) 15.40 (2.95) 15.80 (3.38) 16.45 (3.44) 16.47 (2.85) .070 η2p = 0.029
Suicidality and self-harm, n (%)
Self-harm intention (past month) 37 (28.5)  4 (8.5) 0 (0) <.001 V = 0.325 1 > 3,4
Self-harm behaviour (past month) 7 (5.4) 3 (20.0) 0 (0) 0 (0) .005 V = 0.244 2 > 3,4
Self-harm behaviour (lifetime) 37 (28.5) 9 (60.0) 5 (10.6) 2 (3.8) <.001 V = 0.349 2 > 3,4 & 1 > 4
Suicide plan (past month) 12 (9.2) 1 (6.7) 3 (6.4) 1 (1.9) .332 V = 0.114 
Suicidal ideation (past month) 45 (34.6) 11 (73.3) 9 (19.1) 1 (1.9) <.001 V = 0.397 2 > 1,3,4 & 1,3 > 4
Suicide attempt (past month) 3 (2.3) 1 (6.7) 0 (0) 0 (0) .201 V = 0.134 
Suicide attempt (lifetime) 38 (29.2) 9 (60.0) 4 (8.5) 0 (0) <.001 V = 0.393 1,2 > 3,4
MINI suicidality risk, n (%)
Low 28 (21.5)  3 (6.4) 1 (1.9) .001 V = 0.255 1 > 4
Moderate 21 (16.2)  3 (6.4) 0 (0) .003 V = 0.224 1 > 4
High 21 (16.2)  5 (10.6) 0 (0) .007 V = 0.207 1,3 > 4
CAARMS severity, median (range) 29 (0-74) 88 (38-122) 6 (0-24) 0 (0-12) <.001 η2p = 0.408 2 > 1 > 3 > 4
SPI-A severity, median (range) 7 (0-74) 14 (0-109) 0 (0-7) 0 (0-2) <.001 η2p = 0.338 1, 2 > 3,4
ACES total, median (range) 2 (0-8)  1 (0-5) 0 (0-4) <.001 η2p = 0.111 1 > 4
Comorbidity, median (range) 2 (0-5)  1 (0-3) 0 (0) <.001 η2p = 0.306 1,3 > 4 & 1 > 3
Psychological treatment, n (%)
Current 21 (16.2) 3 (20.0) 5 (10.6) 0 (0) .015 V = 0.207 1,2 > 4
Past 59 (45.4) 9 (60.0) 15 (31.9) 3 (5.7) <.001 V = 0.353 1,2,3 > 4
Medication, n (%)
Antidepressants 46 (35.4) 7 (46.7) 13 (27.7) 0 (0) <.001 V = 0.333 1,2,3 > 4
Mood stabilisers 4 (3.1) 0 (0) 0 (0) 0 (0) .534 V = 0.121 
Antipsychotics 2 (1.5) 2 (13.3) 0 (0) 0 (0) .039 V = 0.243 2 > 1,4
Anxiolytics 8 (6.2) 2 (13.3) 1 (2.1) 0 (0) .060 V = 0.165 
Social functioning (current), median (range) 8 (3-10)  8 (6-9) 9 (8-10) <.001 η2p = 0.224 4 > 1,3 & 3 > 1
Role functioning (current), median (range) 8 (3-9)  8 (5-9) 9 (5-9) <.001 η2p = 0.191 4 > 1,3 & 3 > 1
PAS average, median (range) 1.20 (0-3.43)  0.86 (0-3.86) 0.43 (0-1.64) <.001 η2p = 0.183 1,3 > 4
Social support, mean (SD) 5.05 (0.89)  5.30 (0.87) 6.02 (0.59) <.001 η2p = 0.168 4 > 1,3
Insecure attachment, mean (SD) 1.75 (0.46)  1.41 (0.50) 1.01 (0.46) <.001 η2p = 0.226 1,3 > 4 & 1 > 3
BACS composite score, mean (SD) -0.39 (1.64)  -0.02 (1.38) 0 (1.01) .140 η2p = 0.017 
Note: CHR-P, clinical high-risk for psychosis; FEP, first episode psychosis; CHR-N, clinical high-risk-negative; HC, healthy control; MINI, Mini-International
Neuropsychiatric Interview; CAARMS, Comprehensive Assessment of At-Risk Mental States; SPI-A, Schizophrenia Proneness Instrument, Adult version;
ACES, Adverse Childhood Experiences Scale; PAS, Premorbid Adjustment Scale; BACS, Brief Assessment of Cognition in Schizophrenia.
aEffect sizes were eta squared (η2p) for Kruskal-Wallis H tests (small effect = 0.01, medium effect = 0.06, large effect = 0.14) and Cramer's V for Pearson’s
chi-square or Fisher-Freeman-Halton tests (small effect = 0.1, medium effect = 0.3, large effect = 0.5).
b1 = CHR-P, 2= FEP, 3 = HC, 4 = CHR-N
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participants had significantly fewer years of education, poorer func-
tioning and lower BACS composite score than community-recruited
participants. However, no significant group differences were observed
on suicide-related variables.
3.4 | Predictors of current suicidal ideation in
CHR-P participants
Multivariable logistic regression analysis was used to determine predic-
tors of current suicidal ideation in CHR-P individuals. We did not identify
any sources of multicollinearity among the potential predictor variables.
Predictors of current suicidal ideation in CHR-P participants
included lifetime suicide attempts, lower CAARMS severity, impaired
social functioning and premorbid adjustment and greater comorbidity
although premorbid adjustment did not contribute significantly to the
model (Table 2). This model explained 32.4% of the variance with an
acceptable AUC of 0.797 (p < .001), specificity of 82.4% and sensitiv-
ity of 46.7% (Figure 2).
4 | DISCUSSION
We examined the prevalence of suicidality and self-harm in CHR-P
and FEP samples as well as predictors of current suicidal ideation in
CHR-P individuals. Our findings suggest that suicidality and self-harm
are highly prevalent in community-recruited CHR-P and FEP groups
with the latter at greatest risk. In addition, lifetime suicide attempts,
lower CAARMS severity, impaired social functioning and greater
comorbidity significantly predicted current suicidal ideation in CHR-P
participants.
4.1 | Suicidality and self-harm prevalence
Our findings highlight significant levels of suicidality and self-harm
in CHR-P individuals recruited from the community. Current sui-
cidal ideation was most commonly disclosed with a prevalence rate
of 34.6%, comparable to previous estimates of 30% (DeVylder
et al., 2012) and 42.9% (Gill et al., 2015) within help-seeking UHR
samples. Similarly large proportions of our CHR-P sample reported
lifetime suicide attempts (29.2%), lifetime self-harm behaviour
(28.5%) and current self-harm intention (28.5%). Interestingly, prev-
alence estimates for lifetime suicide attempts are generally lower in
help-seeking UHR samples, ranging between 8.6 and 18%
(Pelizza et al., 2019, 2020; Preti et al., 2009; Taylor et al., 2015).
One possibility is that clinically-recruited UHR participants, through
their established contact with mental health services, have better
coping skills in comparison to community-recruited individuals.
Overall, the current findings demonstrate that high rates of
suicidality and self-harm are not restricted to clinically recruited
UHR samples.
In contrast to previous studies, our results suggest that suicidality
and self-harm are more prevalent in FEP as compared to CHR-P par-
ticipants, especially with regard to current suicidal ideation (L. Pelizza
et al., 2019, 2020; Preti et al., 2009). Our FEP group exhibited preva-
lence rates for current suicidal ideation (73.3%), lifetime self-harm
behaviour (60.0%) and lifetime suicide attempts (60.0%) that were
F IGURE 1 Suicidality and self-harm profile of the total sample (N = 245)
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approximately two to 11 times greater than those typically reported
in FEP samples (Bertelsen et al., 2007; Challis et al., 2013; Pelizza
et al., 2020; Preti et al., 2009), possibly resulting from our focus on
community-recruitment. Indeed, given that only 20.0% of FEP partici-
pants were in current psychological treatment and 13.3% received
antipsychotics, these individuals may not be receiving appropriate
clinical attention and support for their heightened psychotic symp-
toms and associated distress, thereby increasing suicidality risk.
Notably, CHR-N individuals were characterised by relatively modest
suicidality and self-harm, potentially attributable to the lower comorbid-
ity and better functioning observed in this group relative to the CHR-P
sample. Significantly more CHR-N participants reported current suicidal
ideation (19.1%) compared to HCs (1.9%), however; contrasting with the
higher prevalence rates of 33.3% (L. Pelizza et al., 2020) and 45%
(L. Pelizza et al., 2019) reported in help-seeking samples.
4.2 | Predictors of current suicidal ideation in
CHR-P participants
In the CHR-P group, significant predictors of current suicidal ideation
included lifetime suicide attempts, lower CAARMS severity, impaired
social functioning and greater comorbidity. The final model explained
32.4% of the variance in current suicidal ideation, in line with previous
findings in help-seeking UHR cohorts (Bang et al., 2017; L. Pelizza
et al., 2019).
Our results also concur with prior research in UHR and schizo-
phrenia samples wherein depressive mood, increased psychiatric
comorbidity and poor functioning have emerged as predictors of sui-
cidal ideation (Andriopoulos et al., 2011; Bornheimer, 2016; Harvey
et al., 2018; L. Pelizza et al., 2019). Furthermore, these findings are in
accordance with the interpersonal theory of suicide (Joiner, 2005;
Van Orden et al., 2010) which implicates perceived alienation from,
and lack of meaningful connections with, friends, family and others
(i.e., thwarted belongingness). The emergence of lower, rather than
higher, CAARMS severity as a significant predictor of current suicidal
ideation, however, contrasts with previous findings in help-seeking
UHR samples (Bang et al., 2017).
Overall, the strongest predictor of current suicidal ideation was life-
time suicide attempts, concurring with previous findings in schizophrenia
(Kim et al., 2010). Given that suicidal ideation is also highly predictive of
future suicide attempts and completed suicide in both schizophrenia
samples and psychiatric patient populations (Bertelsen et al., 2007; Fosse
et al., 2017; Horwitz et al., 2015; Lopez-Morinigo et al., 2016), effec-
tively identifying CHR-P individuals with current suicidal ideation is a
critical step towards managing risk and reducing suicide deaths.
Contrary to findings from the general population (E.M. Kleiman &
Liu, 2013; Kosidou et al., 2014; Sörberg et al., 2013; Zortea
et al., 2019), social support, insecure attachment orientations and cog-
nitive ability did not emerge as predictors of suicidality, perhaps owing
to differing assessment measures. In addition, although characterised
by excellent specificity, the prediction model yielded limited sensitiv-
ity. This issue is commonly noted for suicide prediction models, which
may limit their clinical value (Kessler et al., 2020). In order to optimise
model performance, future research should consider employing
TABLE 2 Multivariable logistic regression model for suicidal ideation (past month) in CHR-P participants (N = 130)
Variable Beta SE Wald p OR (95% CI) AUC (SE) [95% CI] R2N Sensitivity Specificity
Suicide attempt
(lifetime)
0.994 0.484 4.221 .040 2.701 (1.047–6.969)





−0.496 0.216 5.246 .022 0.609 (0.399–0.931)
Premorbid
adjustment
0.577 0.344 2.804 .094 1.780 (0.906–3.495)
Comorbidity 0.489 0.199 6.030 .014 1.631 (1.104–2.411)
Note: Beta, unstandardised regression coefficient.
Abbreviations: AUC, area under the curve; CI, confidence interval; OR, odds ratio; R2N, Nagelkerke pseudo R
2 statistic.
F IGURE 2 Receiver-operating characteristic curve for the
multivariable logistic regression model predicting suicidal ideation
(past month) in clinical high-risk for psychosis participants (N = 130)
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advanced machine learning methods as well as more comprehensive
predictor sets incorporating, for example, biological predictors.
4.3 | Limitations
The sample size of CHR-P participants with current suicidal ideation
was relatively small, limiting the number of variables that could be
included in a single model and perhaps reducing the generalisability of
the findings.
In addition, information regarding suicidality and self-harm was
elicited via self-report questions—a method particularly susceptible to
social desirability response bias; or to exaggeration by individuals seek-
ing help. Our methodological approach also involved a single retrospec-
tive assessment of suicidality and self-harm (e.g., past month/lifetime).
Given that suicidal ideation is known to fluctuate rapidly over just a
few hours, this approach may be of limited value (E.M. Kleiman
et al., 2017). In order to capture fine-grained variation in suicidality and
self-harm, future research should turn to time-intensive techniques
such as ecological momentary assessment which allow data to be col-
lected repeatedly, in real-time and in naturalistic settings (de Beurs
et al., 2015).
5 | CONCLUSIONS
Our findings emphasise the high prevalence of suicidality and self-
harm in community-recruited CHR-P and FEP individuals. Moreover,
we demonstrated that lifetime suicide attempts, lower CAARMS
severity, impaired social functioning and greater comorbidity were
able to significantly predict current suicidal ideation in CHR-P partici-
pants, with lifetime suicide attempts comprising the strongest predic-
tor. Therefore, the current findings highlight that CHR-P individuals
recruited outside traditional early intervention services represent a
vulnerable group that requires novel approaches for detection; and
early intervention aimed at suicide prevention. Whether prediction
models can be applied to suicidality prevention in CHR-P samples
remains, however, an open question. We expect that, by incorporating
larger collaborative datasets, longitudinal study designs, machine
learning approaches and real-time measures, model performance will
improve, thereby optimising youth mental health.
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